Search Results - "Vugts, Danielle J."
-
1
Pharmacokinetics, brain delivery, and efficacy in brain tumor-bearing mice of glutathione pegylated liposomal doxorubicin (2B3-101)
Published in PloS one (08-01-2014)“…Brain cancer is a devastating disease affecting many people worldwide. Effective treatment with chemotherapeutics is limited due to the presence of the…”
Get full text
Journal Article -
2
Towards PET imaging of the dynamic phenotypes of microglia
Published in Clinical and experimental immunology (01-12-2021)“…There is increasing evidence showing the heterogeneity of microglia activation in neuroinflammatory and neurodegenerative diseases. It has been hypothesized…”
Get full text
Journal Article -
3
PET Imaging of Microglial Activation-Beyond Targeting TSPO
Published in Molecules (Basel, Switzerland) (08-03-2018)“…Neuroinflammation, which involves microglial activation, is thought to play a key role in the development and progression of neurodegenerative diseases and…”
Get full text
Journal Article -
4
The P2X7 receptor tracer [11C]SMW139 as an in vivo marker of neuroinflammation in multiple sclerosis: a first-in man study
Published in European journal of nuclear medicine and molecular imaging (01-02-2020)“…Purpose The novel PET tracer [ 11 C]SMW139 binds with high affinity to the P2X 7 receptor, which is expressed on pro-inflammatory microglia. The purposes of…”
Get full text
Journal Article -
5
Imaging of neuroinflammation in Alzheimer's disease, multiple sclerosis and stroke: Recent developments in positron emission tomography
Published in Biochimica et biophysica acta (01-03-2016)“…Neuroinflammation is thought to play a pivotal role in many diseases affecting the brain, including Alzheimer's disease, multiple sclerosis and stroke…”
Get full text
Journal Article -
6
Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice
Published in PloS one (27-04-2017)“…The purpose of this work was to use various molecular imaging techniques to non-invasively assess GSK2849330 (anti HER3 ADCC and CDC enhanced 'AccretaMab'…”
Get full text
Journal Article -
7
Improving Routine 89Zr‐Immuno‐PET Applications: Mild Iron Removal Can Favor the Use of Fe‐DFO‐N‐suc‐TFP Ester Over p‐NCS‐Bz‐DFO
Published in Journal of labelled compounds & radiopharmaceuticals (30-06-2024)“…ABSTRACT A key aspect for the applicability of 89Zr‐radioimmunoconjugates is inert modification and radiolabeling. The two commercially available bifunctional…”
Get full text
Journal Article -
8
State of the art procedures towards reactive [18F]fluoride in PET tracer synthesis
Published in EJNMMI radiopharmacy and chemistry (12-10-2023)“…Background Positron emission tomography (PET) is a powerful, non-invasive preclinical and clinical nuclear imaging technique used in disease diagnosis and…”
Get full text
Journal Article -
9
PET imaging of P2X7R in the experimental autoimmune encephalomyelitis model of multiple sclerosis using [11C]SMW139
Published in Journal of neuroinflammation (14-10-2020)“…Abstract Background Non-invasive imaging of the activation status of microglia and the ability to identify a pro- or anti-inflammatory environment can provide…”
Get full text
Journal Article -
10
Identification of new molecular targets for PET imaging of the microglial anti-inflammatory activation state
Published in Theranostics (01-01-2018)“…Microglia are potential targets for therapeutic intervention in neurological and neurodegenerative diseases affecting the central nervous system. In order to…”
Get full text
Journal Article -
11
Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an adjunctive immuno-PET imaging study
Published in BMC cardiovascular disorders (13-02-2022)“…In a Phase I study treatment with the serum amyloid P component (SAP) depleter miridesap followed by monoclonal antibody to SAP (dezamizumab) showed removal of…”
Get full text
Journal Article -
12
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor
Published in Pharmaceuticals (Basel, Switzerland) (05-04-2022)“…Multiple small molecule PET tracers have been developed for the imaging of the epidermal growth factor receptor (EGFR). These tracers target the tyrosine…”
Get full text
Journal Article -
13
F8-IL10: A New Potential Antirheumatic Drug Evaluated by a PET-Guided Translational Approach
Published in Molecular pharmaceutics (07-01-2019)“…Antibody fragment F8-mediated interleukin 10 (IL10) delivery is a novel treatment for rheumatoid arthritis (RA). F8 binds to the extra-domain-A of fibronectin…”
Get full text
Journal Article -
14
Efficient synthesis of [18F]trifluoromethane and its application in the synthesis of PET tracers
Published in Chemical communications (Cambridge, England) (01-01-2013)“…A new strategy towards [(18)F]trifluoromethyl-containing compounds is developed. [(18)F]trifluoromethane is synthesised in a fast and efficient manner and…”
Get more information
Journal Article -
15
Phase 0 microdosing PET study using the human mini antibody F16SIP in head and neck cancer patients
Published in Journal of Nuclear Medicine (01-03-2013)“…The aim of this microdosing phase 0 clinical study was to obtain initial information about pharmacokinetics, biodistribution, and specific tumor targeting of…”
Get full text
Journal Article -
16
Immuno-PET Imaging of Atherosclerotic Plaques with [ 89 Zr]Zr-Anti-CD40 mAb-Proof of Concept
Published in Biology (Basel, Switzerland) (06-03-2022)“…Non-invasive imaging of atherosclerosis can help in the identification of vulnerable plaque lesions. CD40 is a co-stimulatory molecule present on various…”
Get full text
Journal Article -
17
Synthesis and preclinical evaluation of [11C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor
Published in EJNMMI research (16-02-2024)“…Background Mutations in the epidermal growth factor receptor (EGFR) kinase domain are common in non-small cell lung cancer. Conventional tyrosine kinase…”
Get full text
Journal Article -
18
Cergutuzumab amunaleukin (CEA-IL2v), a CEA-targeted IL-2 variant-based immunocytokine for combination cancer immunotherapy: Overcoming limitations of aldesleukin and conventional IL-2-based immunocytokines
Published in Oncoimmunology (04-03-2017)“…We developed cergutuzumab amunaleukin (CEA-IL2v, RG7813), a novel monomeric CEA-targeted immunocytokine, that comprises a single IL-2 variant (IL2v) moiety…”
Get full text
Journal Article -
19
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)
Published in NPJ breast cancer (06-01-2024)“…Efficacy of the human epidermal growth factor receptor (HER)2-targeting trastuzumab emtansine (T-DM1) in breast cancer (BC) relies on HER2 status determined by…”
Get full text
Journal Article -
20
The biodistribution and clearance of AlbudAb, a novel biopharmaceutical medicine platform, assessed via PET imaging in humans
Published in EJNMMI research (21-05-2019)“…Conjugation or fusion to AlbudAbs™ (albumin-binding domain antibodies) is a novel approach to extend the half-life and alter the tissue distribution of…”
Get full text
Journal Article